Exane Derivatives’s M.D.C. Holdings, Inc. MDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,005
Closed -$47K 1101
2021
Q3
$47K Sell
1,005
-557
-36% -$28.2K 0.01% 622
2021
Q2
$74.1K Sell
1,562
-3,649
-70% -$209K 0.02% 577
2021
Q1
$310K Buy
5,211
+309
+6% +$16.2K 0.09% 213
2020
Q4
$221K Buy
4,902
+2,953
+152% +$132K 0.06% 300
2020
Q3
$85K Buy
+1,949
New +$77.7K 0.02% 328
2017
Q3
Sell
-1
Closed -$35 658
2017
Q2
$35 Hold
1
﹤0.01% 599
2017
Q1
$30 Hold
1
﹤0.01% 535
2016
Q4
$26 Hold
1
﹤0.01% 603
2016
Q3
$26 Hold
1
﹤0.01% 591
2016
Q2
$24 Sell
1
-2
-67% -$35 ﹤0.01% 518
2016
Q1
$50 Sell
3
-29
-91% -$468 ﹤0.01% 551
2015
Q4
$587 Hold
32
﹤0.01% 415
2015
Q3
$602 Hold
32
﹤0.01% 446
2015
Q2
$689 Sell
32
-3
-9% -$61 ﹤0.01% 452
2015
Q1
$712 Sell
35
-23
-40% -$441 ﹤0.01% 453
2014
Q4
$1.11K Buy
+58
New +$1.06K ﹤0.01% 474

Other funds holding MDC

Exane Derivatives's MDC Position: Q4 2021 in Review

Exane Derivatives sold out of M.D.C. Holdings, Inc. (MDC) in Q4 2021, closing a stake of 1,005 shares — an estimated $47K sold.

Exane Derivatives first reported a position in MDC in Q4 2014 and held it in 16 quarters. The position peaked at $310K in Q1 2021. 327 funds tracked by Wall St. Rank hold MDC as of Q4 2021.

  • Exane Derivatives reported no remaining M.D.C. Holdings, Inc. position as of Q4 2021 after selling out during the quarter.
  • Exane Derivatives sold 1,005 M.D.C. Holdings, Inc. shares in Q4 2021, an estimated $47K.
  • Exane Derivatives first reported a position in M.D.C. Holdings, Inc. in Q4 2014 and held it in 16 quarters.
  • Exane Derivatives's M.D.C. Holdings, Inc. position peaked at $310K in Q1 2021.
  • 327 funds tracked by Wall St. Rank held M.D.C. Holdings, Inc. as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.